In 2005, the ACS Green Chemistry Institute® and global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable to encourage innovation while catalyzing the integration of green chemistry and green engineering in the pharmaceutical industry. The activities of the Roundtable reflect its member's shared belief that the pursuit of green chemistry and engineering is imperative for business and environmental sustainability.
Recent Publication: Special Report: Toward Sustainable Engineering Practices in Biologics Manufacturing
Tool Released: Online Reagent Guide
Member companies who are part of the ACS GCI Pharmaceutical Roundtable come together to catalyze innovative approaches to improving process efficiency and product quality through green chemistry and engineering. By working together, the Roundtable provides leadership and influence throughout the industry and supply chain. For example, the Pharmaceutical Roundtable has awarded over $1.84 million dollars in funding to further key research priorities for greener chemistries. In addition, the Roundtable continues to develop a valuable set of tools including a solvent selection guide, Process Mass Intensity/LCA calculator, and a powerful reagent guide.
The ACS GCI Pharmaceutical Roundtable invites all corporations meeting the definition of membership to consider joining. Companies are encouraged to join if they are committed to the integration of green chemistry and green engineering into the business of drug discovery and production.
Find out more about Membership
ACS GCIPR's mission is to catalyze the implementation of green chemistry and green engineering in the global pharmaceutical industry.
The ACS GCI Pharmaceutical Roundtable is dedicated to developing high quality green chemistry tools for Roundtable members as well as the public.
Publicly Accessible Tools
Member Only Tools
For more information, see the Green Chemistry Tools page
The ACS GCI Pharmaceutical Roundtable is a frequent and influential publisher. For example, "Key green chemistry research areas—a perspective from pharmaceutical manufacturers" published in Green Chemistry in 2007 has received over 283 citations. The Roundtable's most recent papers and presentations are:
For a complete list, see Publications.